Creso Pharma

What Creso Pharma does

Melodiol Global Health Limited (formerly Creso Pharma) is an ASX-listed (ASX:ME1) holding company headquartered in Nedlands, Western Australia that operates a diversified portfolio of plant-based businesses across recreational cannabis, medical cannabis, CBD, psychedelics, and natural consumer goods. Its wholly-owned subsidiaries include Mernova (Canadian recreational cannabis produced through a state-of-the-art indoor cultivation facility in Nova Scotia), Health House International (Australian medical cannabis distribution serving patients and healthcare providers), Creso Pharma Switzerland (CBD research, development, and international commercialization), Halucenex Life Sciences (psychedelics applied science), impACTIVE (CBD topical products targeting athletes), and Sierra Sage Herbs (plant-based consumer goods sold through retail and e-commerce).

The company operates a platform-plus-subsidiaries model in which Melodiol acts as the parent brand coordinating complementary operational units across Canada, Australia, and Switzerland. Revenue is generated through five distinct streams — recreational cannabis, medical cannabis distribution, CBD products, psychedelics, and plant-based consumer goods — using a combination of direct cultivation sales, channel/reseller distribution, and e-commerce. Customer segments span recreational cannabis consumers, medical cannabis patients, CBD wellness consumers, psychedelic therapy patients, and health-conscious/athlete consumers. Marketing and investor communication are conducted through ASX announcements, investor presentations, annual and financial reports, and direct email alerts to shareholders.

Name

Creso Pharma

Legal name

Melodiol Global Health Limited

Website

https://cresopharma.com

Company type

Public

Operating status

Operating

Headcount range

1–10 employees

Short description

Melodiol Global Health Limited (formerly Creso Pharma) is an ASX-listed holding company operating a diversified portfolio of plant-based businesses across recreational and medical cannabis, CBD, psychedelics, and natural consumer goods through wholly-owned subsidiaries in Canada, Australia, and Switzerland.

Ownership category

akta.pro rank

Product category

Cannabis & CBD Products

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412), Pharmacies and Drug Retailers (45611)

SIC

Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)

akta.pro primary industry

Adult-Use (Recreational) Cannabis Dispensaries (CRANAFAA)

akta.pro secondary industries

Medical Cannabis Dispensaries (CRANAFAB), Cannabis Dispensary + Wellness/Apothecary Format (Supplements, Skincare, etc.) (CRANAFAJ)

Keywords

• Cannabis cultivation
• Medical cannabis distribution
• CBD products
• Psychedelic therapeutics
• Plant-based consumer goods

Headquarters

HQ city

Nedlands

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Recreational Cannabis: Revenue from recreational cannabis products through Mernova operations in Canada
2. Medical Cannabis Distribution: Revenue from medical cannabis distribution through Health House International in Australia
3. CBD Products: Revenue from CBD research, development and commercialization through Creso Pharma Switzerland
4. Psychedelics: Revenue from psychedelics applied science through Halucenex Life Sciences
5. Plant Based Consumer Products: Revenue from plant based consumer goods through Sierra Sage Herbs and impACTIVE product lines

Distribution channels5 records

Marketing channels5 records

Core offering

Melodiol Global Health Limited (formerly Creso Pharma) curates and delivers a portfolio of plant-based functional products across recreational cannabis, medical cannabis, CBD, psychedelics, and plant-based consumer goods. Operating through wholly-owned subsidiaries (Mernova, Health House International, Creso Pharma Switzerland, Halucenex Life Sciences, impACTIVE, and Sierra Sage Herbs), the company produces, distributes, and commercialises cannabis and CBD products in Canada, Australia, and Switzerland.

Product overview

Melodiol operates as a global platform providing plant-based functional products through a multi-brand portfolio. The core company curates offerings across recreational and medical cannabis, CBD, psychedelics, and plant-based consumer goods. Its portfolio includes Mernova (Canadian recreational cannabis), Health House International (Australian medical cannabis distribution), Creso Pharma Switzerland (CBD R&D and commercialisation), Halucenex Life Sciences (psychedelics applied science), impACTIVE (CBD topical products for athletes), and Sierra Sage Herbs (plant-based consumer products). The architecture functions as a platform-plus-subsidiaries model where Melodiol serves as the parent brand coordinating complementary operational units.

Differentiator

Problem solved

Functional benefit

Products and services

• Mernova Recreational Cannabis
• Health House International Medical Cannabis Distribution
• Creso Pharma Switzerland CBD Products
• Halucenex Life Sciences Psychedelics
• impACTIVE CBD Topical Products
• Sierra Sage Herbs Plant-Based Products

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Compass Pathways: Clinical-stage mental health company developing psilocybin therapy for treatment-resistant depression. Comparable psychedelic applied science and clinical focus to Halucenex.
• Cronos Group: Canadian cannabis producer with international operations and consumer product lines, including CBD wellness. Comparable in the recreational cannabis and CBD verticals.
• Charlotte's Web Holdings: US-based CBD wellness company producing plant-based hemp extract products. Closely comparable to Melodiol's CBD consumer product verticals (Sierra Sage Herbs, impACTIVE).
• Canopy Growth Corporation: Canadian-headquartered cannabis producer with diversified global operations in recreational, medical and CBD. Comparable multi-jurisdictional cannabis platform to Melodiol.
• OrganiGram Holdings: Canadian licensed cannabis producer focused on recreational and medical products. Directly comparable to Mernova's cultivation-driven Canadian business.
• Aurora Cannabis: Canadian licensed cannabis producer with global medical and recreational operations across multiple countries. Directly comparable to Mernova's Canadian cultivation and Melodiol's multi-jurisdiction strategy.
• Mind Medicine (MindMed): Clinical-stage psychedelic medicine company developing psychedelic-assisted therapies. Directly comparable to Melodiol's Halucenex Life Sciences psychedelics subsidiary.
• Tilray Brands: Global cannabis and CPG company with Canadian cultivation, medical distribution and consumer products. Closely comparable across Melodiol's recreational, medical and consumer wellness verticals.

Emerging players

• Zelira Therapeutics: Australia-based clinical-stage cannabinoid and psychedelic medicine company. Closely comparable as a smaller ASX-listed peer operating at the intersection of medical cannabis and psychedelic research.

Broad incumbents

• Curaleaf Holdings: Largest US multi-state cannabis operator with cultivation, processing and retail across recreational and medical. Comparable as a broad incumbent in the cannabis space, though US-focused.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/creso-pharma

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Creso Pharma